The various aggregation states of beta-amyloid 1-42 mediate different effects on oxidative stress, neurodegeneration,

Elena Tamagno1, Paola Bardini, Michela Guglielmotto

  • 1General Pathology Section, Department of Experimental Medicine and Oncology, University of Turin, Corso Raffaello 30, 10125 Turin, Italy. elena.tamagno@unito.it

Insights

Soluble beta-amyloid (A beta) oligomers and prefibrillar forms cause significant oxidative stress and neuronal death in Alzheimer disease models. Fibrillar A beta, however, uniquely increases BACE-1 expression.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • The amyloid cascade hypothesis implicates beta-amyloid (A beta) plaques in Alzheimer disease pathogenesis.
  • Correlation between plaque load and dementia severity is weak, suggesting other A beta species may be toxic.
  • Soluble A beta oligomers are increasingly recognized as potent neurotoxic agents.

Purpose of the Study:

  • To investigate the differential neurotoxic effects of fibrillar, prefibrillar, and oligomeric A beta(1-42) species.
  • To characterize the impact of these A beta forms on oxidative stress, neuronal cell death, and BACE-1 activity.

Main Methods:

  • Exposure of NT2 neuronal cells to distinct A beta(1-42) aggregation states (fibrillar, prefibrillar, oligomeric).
  • Measurement of oxidative stress markers (4-hydroxynonenal, hydrogen peroxide).
  • Assessment of apoptotic and necrotic cell death.
  • Quantification of BACE-1 expression and activity.

Main Results:

  • Prefibrillar and oligomeric A beta(1-42) induced significantly higher levels of oxidative stress markers compared to fibrillar A beta(1-42).
  • Elevated oxidative stress correlated with accelerated apoptotic and necrotic neuronal cell death.
  • Only fibrillar A beta(1-42) significantly upregulated BACE-1 expression and activity.

Conclusions:

  • Soluble, non-fibrillar A beta species (oligomers and prefibrillar forms) are potent inducers of oxidative stress and neuronal death.
  • Fibrillar A beta exhibits distinct effects, primarily upregulating BACE-1, suggesting different roles in Alzheimer disease.
  • These findings highlight the complex and differential roles of A beta aggregation states in Alzheimer disease pathology.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...